Purchase Order 75N95023P00317
Award Date 5/30/23
Potential Completion Date 3/31/26
Potential Value $1.8M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
- The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
- This federal contract award, with a total ceiling value of $36,320.00, was made by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract was awarded to the prime contractor 10X Genomics, Inc. on December 19, 2024 and is for the procurement of 10X Genomics' Chromium X platform and associated single-cell analysis kits and reagents. This is a firm fixed-price...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey. The order is for photoredox chemistry discovery services with a completion date of November 4, 2022. No set-aside designation was used for this award to support the National Center's programs in translational sciences. The potential value matches the award amount to...
- This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Cayman Chemical Co Inc., a small business manufacturer of biochemical products and research tools. The $132,476.28 firm fixed-price purchase order is for the supply of "Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT)," which supports NCATS' drug discovery and translational research initiatives. Cayman...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $141,500 firm-fixed-price purchase order to Chemdiv, Inc. for the acquisition of an 11,000 compound methyltransferase library. This non-competitive award was made under simplified acquisition procedures without a set-aside designation. The contract required delivery of the compound library within 8 weeks. Chemdiv, Inc. is a for-profit organization providing drug...
- This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $18,028.80 to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract, which does not have a set-aside designation, was awarded on June 5, 2019, with a completion date of December 13, 2019. Reaction Biology Corporation, a drug discovery contract research organization,...
- This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Compound Focus Inc. for the operation and maintenance of the NCATS Small Molecule Repository. The contract has a ceiling value of $2,093,753.88 and was awarded on June 14, 2016, with a period of performance through June 13, 2017. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, and there is no set-aside designation. The contract is not...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $391,467 firm fixed price purchase order to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, to acquire 97 specified chemical compounds for NCATS' pre-clinical library in support of its antiviral initiative. The solicitation sought quotes for delivery of the chemical compounds to locations in the United States by September 2022, with...